Concepedia

Magdalena Koziczak‐Holbro

MK

5

Publications

202

Citations

5

H-Index

2007

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Scripps Research Institute

Magdalena Koziczak‐Holbro is an author at Novartis (Switzerland) specializing in cell death, cell biology, and systems biology.

Top concepts

Publications per year

2007–2019

5

Publications

5

IRAK-4 Kinase Activity Is Required for Interleukin-1 (IL-1) Receptor- and Toll-like Receptor 7-mediated Signaling and Gene Expression

Magdalena Koziczak‐Holbro, Claire Joyce, Anton Glück et al. · Journal of Biological Chemistry · 2007 · 89 citations · Full text

The critical role of kinase activity of interleukin‐1 receptor–associated kinase 4 in animal models of joint inflammation

Magdalena Koziczak‐Holbro, Amanda Littlewood‐Evans, Bernadette Pöllinger et al. · Arthritis & Rheumatism · 2009 · 47 citations

IRAK‐4 kinase activity‐dependent and ‐independent regulation of lipopolysaccharide‐inducible genes

Magdalena Koziczak‐Holbro, Anton Glück, Claude Tschopp et al. · European Journal of Immunology · 2008 · 36 citations · Full text

Pharmacological Characterization of a Novel 5-Hydroxybenzothiazolone-Derived β2-Adrenoceptor Agonist with Functional Selectivity for Anabolic Effects on Skeletal Muscle Resulting in a Wider Cardiovascular Safety Window in Preclinical Studies

Magdalena Koziczak‐Holbro, Dean F. Rigel, Bérengère Dumotier et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 18 citations · Full text

Solving the IRAK-4 Enigma: Application of Kinase-Dead Knock-In Mice

Magdalena Koziczak‐Holbro, Claire Joyce, Anton Glück et al. · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · 2008 · 12 citations

, , +9

Rows per page

1–5 of 5